Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Allergy & Immunology
•
Immunosuppression
•
Anaphylaxis
•
Allergy
•
Immunology
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Patient with seropositive RA, immunodeficiency, and idiopathic anaphylaxis.
Related Questions
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
When trying to increase infliximab for active disease (inflammatory arthritis or sarcoidosis), do you prefer to increase dosage or reduce frequency between doses?
Can lupus anticoagulant be positive despite a normal aPTT?
What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis?